GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene Biotek Ltd (BOM:526139) » Definitions » YoY Rev. per Sh. Growth

Transgene Biotek (BOM:526139) YoY Rev. per Sh. Growth : 25.00% (As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Transgene Biotek YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Transgene Biotek's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was 25.00%.

Transgene Biotek's Revenue per Share for the three months ended in Mar. 2025 was ₹0.01.


Transgene Biotek YoY Rev. per Sh. Growth Historical Data

The historical data trend for Transgene Biotek's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgene Biotek YoY Rev. per Sh. Growth Chart

Transgene Biotek Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -50.00 -36.36 357.14 9.38

Transgene Biotek Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -53.33 14.29 12.50 25.00

Transgene Biotek YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Transgene Biotek's YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY Rev. per Sh. Growth (A: Mar. 2025 )
=(Revenue per Share (A: Mar. 2025 )-Revenue per Share (A: Mar. 2024 ))/ | Revenue per Share (A: Mar. 2024 ) |
=(0.035-0.032)/ | 0.032 |
=9.38 %

Transgene Biotek's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=(Revenue per Share (Q: Mar. 2025 )-Revenue per Share (Q: Mar. 2024 )) / | Revenue per Share (Q: Mar. 2024 )) |
=(0.01-0.008)/ | 0.008 |
=25.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Transgene Biotek YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Transgene Biotek's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Transgene Biotek Business Description

Traded in Other Exchanges
N/A
Address
Anrich Industrial Area, Plot No. 69 and 70, IDA Bollaram, Sangareddy District, Medak, TG, IND, 502325
Transgene Biotek Ltd is an India-based research and development company. It is engaged in the research and development of molecules and technologies for the production of active pharmaceutical ingredients and other pharmaceutical products. The company is operating only in one segment of Bulk Drugs. Its product portfolio includes TrabiDHA, Tracolimus, and Orlistat. It generates revenue from the sale of goods and services.

Transgene Biotek Headlines

No Headlines